Honeywell reported a significant 18% organic sales decline in Q2 and suspended full-year guidance due to the COVID-19 pandemic, indicating substantial short-term challenges. While the company implemented effective cost-cutting measures and saw growth in sectors like PPE and warehouse automation, the overall cautious outlook is likely to exert downward pressure on the stock in the next couple of weeks.

[-1]